Cipla Ltd

CIPLA

Company Profile

  • Business description

    Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective, CNS, and various other key therapeutic segments. The bulk of its sales are generated in India, although it maintains a large world-wide presence. Cipla's growth plan focuses on new product launches. It has two segments Pharmaceuticals and new ventures. It derives maximum revenue from Pharmaceuticals Segment.

  • Contact

    Ganpatrao Kadam Marg
    Cipla House, Peninsula Business Park
    Lower Parel
    MumbaiMH400 013
    IND

    T: +91 2224826000

    https://www.cipla.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    45,189

Stocks News & Analysis

stocks

Nvidia Earnings: No signs of a slowdown in demand for AI chips

A selloff in Nvidia stock on the earnings news looks like a buying opportunity to us.
stocks

ASX results reaction: WiseTech, Woolies, Sigma and more

A round up of notable stories and reactions as ASX reporting season rolls on.
stocks

WiseTech result disappoints, but the future looks bright

Markets appear underwhelmed by recent sales growth, however, our kingmaker thesis is intact.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,243.009.000.10%
CAC 407,703.9058.70-0.76%
DAX 4023,902.21137.71-0.57%
Dow JONES (US)45,519.39117.51-0.26%
FTSE 1009,187.3429.48-0.32%
HKSE25,077.6278.800.32%
NASDAQ21,472.91232.25-1.07%
Nikkei 22542,718.47110.32-0.26%
NZX 50 Index12,930.7327.650.21%
S&P 5006,461.8739.99-0.62%
S&P/ASX 2008,973.104.100.05%
SSE Composite Index3,857.9314.330.37%

Market Movers